JPS6133122A - Preparation of tablet having improved disintegrating property - Google Patents
Preparation of tablet having improved disintegrating propertyInfo
- Publication number
- JPS6133122A JPS6133122A JP59154914A JP15491484A JPS6133122A JP S6133122 A JPS6133122 A JP S6133122A JP 59154914 A JP59154914 A JP 59154914A JP 15491484 A JP15491484 A JP 15491484A JP S6133122 A JPS6133122 A JP S6133122A
- Authority
- JP
- Japan
- Prior art keywords
- crude drug
- cellulose glycolate
- adsorbent
- tablet
- tablets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【発明の詳細な説明】
(イ)発明の目的
〔産業上の利用分野〕
この発明は崩壊性良好な錠剤の製法に関し、特に生薬の
錠剤の製法に関する。DETAILED DESCRIPTION OF THE INVENTION (a) Object of the invention [Field of industrial application] This invention relates to a method for manufacturing tablets with good disintegration, and particularly to a method for manufacturing tablets of crude drugs.
生薬は副作用が少なく、種々の薬理作用を呈し各種の用
途がある。生薬の薬効成分を利用する方法の一つに生薬
の粉砕物を熱水で処理して得た浸液や熱液をそのまま服
用する方法がある。また服用を′容易にするため錠剤化
が行われている。すなわち上記浸液や熱液を含む抽出液
をできるだけ濃縮しておいて適当な賦形剤を混合して粉
末化してこれに錠剤化に必要な伯の添加剤(例えば滑沢
剤、崩壊剤など)を加えてから打錠される。Herbal medicines have few side effects, exhibit a variety of pharmacological actions, and have a variety of uses. One of the methods of utilizing the medicinal components of crude drugs is to treat pulverized crude drugs with hot water and take the immersion liquid or hot liquid as it is. It is also made into tablets to make it easier to take. That is, the extract containing the soaking liquid and hot liquid is concentrated as much as possible, mixed with appropriate excipients, powdered, and added with additives necessary for tabletting (e.g., lubricants, disintegrants, etc.). ) is added and then compressed into tablets.
上記従来技術において浸液や熱液をそのまま服用する場
合は容積が大で好ましくないにおいや味のために服用し
にくいことまた腐敗しやすく保存性が悪いという問題点
がある。また錠剤化する場合は一般に抽出液をできるだ
け濃縮しておいてこれを錠剤化するが、この濃縮に手数
と時間を要する。In the above-mentioned conventional technology, when taking the immersion liquid or hot liquid as is, there are problems in that the volume is large and it is difficult to take it due to unpleasant odor and taste, and it is easy to spoil and has poor storage stability. Furthermore, in the case of tabletting, the extract is generally concentrated as much as possible and then tabletted, but this concentration requires time and effort.
この発明はこれらの問題点を解消して服用しやすく、し
かも高い硬度で崩壊性の良好な生薬の錠剤の簡便な製法
を提供するものである。The present invention solves these problems and provides a simple method for producing crude drug tablets that are easy to take, have high hardness, and have good disintegration properties.
(ロ)発明の構成
この発明は生薬の水性抽出液又はその濃縮液に繊維素グ
リコール酸又はそのカルシウム塩を添加混合し、乾燥さ
せて得られる粉体を、そのまま又は所望により賦形剤、
滑沢剤とともに圧縮成形することを特徴とする崩壊性良
好な錠剤の製法を提供するものである。(B) Structure of the Invention This invention involves adding and mixing cellulose glycolic acid or its calcium salt to an aqueous extract of a herbal medicine or its concentrate, and drying the resulting powder, which can be used as it is or optionally with excipients.
The present invention provides a method for producing tablets with good disintegration, which is characterized by compression molding together with a lubricant.
薬剤が油状或いは水溶液の場合これを粉体に吸着させ粉
末状として圧縮成形することに従来から行われており例
えば微粒子の酸化ケイ素などが吸着剤として使用されて
いる。When the drug is in the form of an oil or an aqueous solution, it has conventionally been adsorbed onto a powder and compression-molded as a powder. For example, fine particles of silicon oxide have been used as the adsorbent.
この発明は、繊維素グリコール酸又はそのカルシウム塩
を生薬の吸着剤として使用するものである。これらはい
ずれも錠剤崩壊剤として日本薬局方に収載のものであり
、水不溶性であるが自重の3倍程度の水を吸収する性質
を有し、また単独でも圧縮成形して錠剤とすることがで
きる。This invention uses cellulose glycolic acid or its calcium salt as an adsorbent for crude drugs. All of these are listed in the Japanese Pharmacopoeia as tablet disintegrants, and although they are water-insoluble, they have the property of absorbing about three times their own weight in water, and can be compressed into tablets even when used alone. can.
生薬の水抽出液又はその濃縮液を粉体の繊維素グリコー
ル酸又はそのカルシウム塩に混合すると、速やかに吸着
される。これら製剤工業界で業通に使用されている通風
乾燥機を用いて水分的1〜10%の範囲に容易に乾燥す
ることができる。したがって濃縮液の場合でも軽度の濃
縮でよい。When an aqueous extract of a crude drug or its concentrate is mixed with powdered cellulose glycolic acid or its calcium salt, it is rapidly adsorbed. These can be easily dried to a moisture content of 1 to 10% using a ventilation dryer commonly used in the pharmaceutical industry. Therefore, even in the case of a concentrated solution, a slight concentration is sufficient.
一般に粉体の圧縮成型には適量の水分の存在が必要であ
ると言われているが1asi素グリコール酸又はそのカ
ルシウム塩の場合、上記の水分m以下に過剰乾燥される
ことは通常の乾燥条件ではほとんどなく、過剰乾燥され
ても通常の気候条件に放置すれば上記水分量に容易に回
復する。このように乾燥した生薬を含む本願発明の吸着
剤は圧縮成型性にすぐれ打錠が容易である。例えば生薬
の滑沢剤の添加により圧縮成型が可能であって、高濃度
で生薬の有効成分を含有する錠剤をうることができる。It is generally said that compression molding of powder requires the presence of an appropriate amount of moisture, but in the case of 1asi glycolic acid or its calcium salt, it is normal drying conditions to overdry to less than the above moisture content m. Even if it is overdried, it will easily recover to the above moisture content if left under normal climatic conditions. The adsorbent of the present invention containing the dried crude drug has excellent compression moldability and is easy to tablet. For example, by adding a crude drug lubricant, compression molding is possible, and tablets containing the active ingredients of the crude drug at a high concentration can be obtained.
製剤にあたって他の賦形剤を添加することは任意である
が高硬度で崩壊性の高い錠剤をうろことができる。これ
らの製剤化時の物性の良好であることが、従来の吸着剤
例えば酸化ケイ素などに比べて優れた点である。Although it is optional to add other excipients to the formulation, tablets with high hardness and high disintegration can be obtained. The good physical properties of these formulations are superior to conventional adsorbents such as silicon oxide.
実施例1及び2並びに比較例1 甘草エキスを次の方法で作製した。Examples 1 and 2 and Comparative Example 1 Licorice extract was produced by the following method.
(1) 乾燥した甘草300gを水1500ccに浸
漬し、2日間静置後、目の細いガーゼを用いて固形分と
抽出液(1)に分離した。(1) 300 g of dried licorice was immersed in 1500 cc of water, left to stand for 2 days, and then separated into solid content and extract liquid (1) using fine gauze.
(2) 固形分に水1000ccをさらに加えて一日
間静置、同様にして抽出液(2)を分離した。(2) 1000 cc of water was further added to the solid content, left to stand for one day, and extract liquid (2) was separated in the same manner.
(3)抽出液(1)と抽出液(′2Jを合せて加熱し、
約60CCにまで濃縮して、甘草エキス(固形分、約4
6%)をえた。(3) Combine extract (1) and extract ('2J) and heat.
Concentrate to approximately 60 CC and extract licorice extract (solid content, approximately 4
6%).
上記甘草エキスに対し、略同船の繊維素グリコール酸カ
ルシウム(ECG505 ニチリン化学工業製) (
実施例1)、繊維素グリコール酸(NS300、ニチリ
ン化学工業製)(実施例2)、微結晶セルロース(アビ
セルPHIOI 旭化成製)(比較例1)をそれぞれ
混合したところ、それぞれ完全に吸収された。これらを
70℃で約12時間通風乾燥し、薬効成分が吸着された
粉体とした。これらの粉体に対し0.5%の滑沢剤(ス
テアリン酸カルシウム)を添加し、〔微結晶セルロース
の場合にさらに崩壊剤(EC0505)を5%添添加径
径15m、重量700111111の錠剤を4t4の圧
力で打錠し成型した。In contrast to the above licorice extract, approximately the same ship's cellulose calcium glycolate (ECG505 manufactured by Nichirin Kagaku Kogyo) (
Example 1), cellulose glycolic acid (NS300, manufactured by Nichirin Kagaku Kogyo) (Example 2), and microcrystalline cellulose (Avicel PHIOI manufactured by Asahi Kasei) (Comparative Example 1) were mixed, and each was completely absorbed. These were dried with ventilation at 70° C. for about 12 hours to obtain a powder in which medicinal ingredients were adsorbed. To these powders, 0.5% of a lubricant (calcium stearate) was added, and in the case of microcrystalline cellulose, 5% of a disintegrant (EC0505) was added. It was compressed into tablets and molded at the same pressure.
得られた錠剤の硬度(モンサント硬度計)、人工胃液(
温度36〜31℃)中の崩壊に要する時間、を第1表に
示す。尚、得られた錠剤を65%RH120℃に1昼夜
放置したときの含有水分量を併記したが、比較例1に比
べ実施例1と2は水分量が約2倍であるにもかかわらず
同等の高硬度を有し、崩壊性は著しく優れている。The hardness of the obtained tablet (Monsanto hardness tester), artificial gastric fluid (
Table 1 shows the time required for disintegration at a temperature of 36-31°C. In addition, the moisture content when the obtained tablets were left at 65% RH 120°C for one day and night is also listed, but compared to Comparative Example 1, Examples 1 and 2 are equivalent even though the moisture content is about twice as much. It has high hardness and extremely good disintegration properties.
第1表
甘草エキスは3日間放置すると変質したが錠剤は1ケ月
後も変質をみとめなかった。The licorice extract in Table 1 deteriorated in quality after being left for 3 days, but no change in quality was observed in the tablets even after 1 month.
実施例3 次の手順で朝鮮人参エキス含有粉末を作製した。Example 3 A ginseng extract-containing powder was prepared using the following procedure.
(1)朝鮮人参の根の乾燥品18gを水600ccに浸
漬し、ゆるやかに5時間に煮沸させた。その後加熱を強
め、約300ccに濃縮した。(1) 18 g of dried ginseng root was immersed in 600 cc of water and gently boiled for 5 hours. Thereafter, the heating was increased and the volume was concentrated to about 300 cc.
(2J 遠心分離して固形分を除去し、抽出液分にS
維素グリコール酸カルシウム(E CG 505) 2
0Qを加え、エタノールを加えながら80℃で減圧下水
/エタノールを溜去した。(2J centrifuge to remove solids, add S to the extract
Fibrin calcium glycolate (E CG 505) 2
0Q was added, and the water/ethanol was distilled off under reduced pressure at 80° C. while adding ethanol.
(3)最終的にエタノールのスラリーからエタノールを
溜去し、得られた粉末を70℃で約12時間通風乾燥し
た。収量21.5gであった。(3) Finally, ethanol was distilled off from the ethanol slurry, and the resulting powder was dried with ventilation at 70° C. for about 12 hours. The yield was 21.5g.
得られたエキス含有粉末を実施例1と同様の方法で打錠
し、硬度30k(]以上、崩壊時間7分〜8分の錠剤を
得た。The obtained extract-containing powder was tableted in the same manner as in Example 1 to obtain tablets with a hardness of 30k or more and a disintegration time of 7 to 8 minutes.
尚、上記エキス含有粉末に、粉体のまま服用することも
可能であり、保存性も良好であった。It should be noted that the above extract-containing powder could be taken as a powder, and had good storage stability.
(ハ)発明の効果
この発明によれば、手数と時間がかからず、服用しやす
くしかも高硬度で崩壊性の良好な生薬の錠剤を製造する
ことができる。(C) Effects of the Invention According to the present invention, it is possible to produce crude drug tablets that are easy to take, have high hardness, and have good disintegration properties without requiring much labor and time.
Claims (1)
ル酸又はそのカルシウム塩を添加混合し、乾燥させて得
られる粉体を、そのまま又は所望により賦形剤、滑沢剤
とともに圧縮成形することを特徴とする崩壊性良好な錠
剤の製法。1. Compression molding of the powder obtained by adding and mixing cellulose glycolic acid or its calcium salt to an aqueous extract of a crude drug or its concentrate and drying it as it is or with excipients and lubricants as desired. A method for producing tablets with good disintegration characteristics.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59154914A JPS6133122A (en) | 1984-07-25 | 1984-07-25 | Preparation of tablet having improved disintegrating property |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59154914A JPS6133122A (en) | 1984-07-25 | 1984-07-25 | Preparation of tablet having improved disintegrating property |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6133122A true JPS6133122A (en) | 1986-02-17 |
Family
ID=15594716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59154914A Pending JPS6133122A (en) | 1984-07-25 | 1984-07-25 | Preparation of tablet having improved disintegrating property |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6133122A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004006945A1 (en) * | 2002-07-12 | 2004-01-22 | Tsumura & Co. | Tablet composition containing chinese orthodox medicine extract and process for producing the same |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56152416A (en) * | 1980-04-25 | 1981-11-26 | Tsumura Juntendo Inc | Preparation of chinese herbal remedy tablet |
-
1984
- 1984-07-25 JP JP59154914A patent/JPS6133122A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56152416A (en) * | 1980-04-25 | 1981-11-26 | Tsumura Juntendo Inc | Preparation of chinese herbal remedy tablet |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004006945A1 (en) * | 2002-07-12 | 2004-01-22 | Tsumura & Co. | Tablet composition containing chinese orthodox medicine extract and process for producing the same |
US7326427B2 (en) | 2002-07-12 | 2008-02-05 | Tsumura & Co. | Tablet composition containing Kampo medicinal extract and its manufacturing process |
JP4774739B2 (en) * | 2002-07-12 | 2011-09-14 | 株式会社ツムラ | Kampo extract-containing tablet composition and method for producing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6286383B2 (en) | Solid pharmaceutical composition | |
JP5344289B2 (en) | Kampo extract-containing tablet composition | |
KR20160040213A (en) | Pharmaceutical composition, preparation method therefor and use thereof | |
KR20240095109A (en) | Health functional foods for relieving pain and antioxidant activity | |
JP2017521446A (en) | Combination of valerian root extract and lavender oil for the treatment of sleep disorders | |
JP6294943B2 (en) | Solid pharmaceutical composition | |
JP6434570B2 (en) | Solid pharmaceutical composition | |
JP2017160148A (en) | Silymarin-highly containing tablet | |
JP2017155061A (en) | Solid pharmaceutical composition | |
JPS6133122A (en) | Preparation of tablet having improved disintegrating property | |
KR101269665B1 (en) | Film coated tablet comprising cardus marianus extract and curcuma xanthorhiza extract, and a method of preparation thereof | |
JP2001181195A (en) | Solid preparation containing tetousutore extract as active ingredient | |
JP3142192B2 (en) | Blood lipid improving agent and composition containing the same | |
JP2022130003A (en) | Solid preparation containing chinese medicine extract or vegetable herbal medicine extract, and method for producing the same, and method for improving the ease of disintegration of solid preparation | |
JPH0812569A (en) | Solid substance adsorbing carnitine chloride thereon | |
CN106109523A (en) | A kind of crocin and Carlina acaulis composite chewable tablet and preparation method thereof | |
CN109331143B (en) | A kind of Cistanche compound and its preparation method | |
CN100363018C (en) | Honeysuckle soft capsule preparation and preparation method thereof | |
JP3183758B2 (en) | Blood neutral fat ameliorating agent, method for producing the same, and composition containing the same | |
JP6434674B2 (en) | Solid pharmaceutical composition | |
JP6434673B2 (en) | Solid pharmaceutical composition | |
RU2243781C1 (en) | Biologically active supplement for prophylaxis of cardiovascular diseases | |
JP6927764B2 (en) | Tablets containing Seihaito extract powder | |
JP2005143328A (en) | Granular angelica utilis and method for producing the same | |
RU2531092C1 (en) | Method for preparing antiulcer gastroretentive agent |